ANDRE-JACQUES AUBERTON-HERVE - 15 Jul 2021 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director
Signature
/s/ Andre-Jacques Auberton-Herve
Issuer symbol
BNKL
Transactions as of
15 Jul 2021
Net transactions value
+$210,201
Form type
4
Filing time
21 Jun 2022, 17:49:00 UTC
Next filing
20 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Options Exercise $186,501 +51,878 +23% $3.60 276,353 15 Jul 2021 Shares held through Star SCI or 4A Consulting and Engineering F1
transaction BNKL Common Stock, par value $0.001 per share Options Exercise $23,700 +7,500 +2.7% $3.16 283,853 15 Jul 2021 Shares held through Star SCI or 4A Consulting and Engineering F1
holding BNKL Common Stock, par value $0.001 per share 95,149 15 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNKL Stock Option (right to buy) Options Exercise $0 -51,878 -45% $0.000000 63,881 15 Jul 2021 Common Stock, par value $0.001 per share 51,878 $3.60 Direct F1
transaction BNKL Stock Option (right to buy) Options Exercise $0 -7,500 -100% $0.000000* 0 15 Jul 2021 Common Stock, par value $0.001 per share 7,500 $3.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Payment of exercise price was satisfied through the satisfaction of an Issuer promissory note held by the reporting person.
F2 The options vest 2,500 on May 31, 2019, 2,500 on November 30, 2019 and 2,500 on May 31, 2020.